Alluvi tirzepatide is emerged as a promising therapeutic option for the control of metabolic disorders. This initial evaluation explored the efficacy and safety of tirzepatide 40mg in experimental models of metabolic syndrome. The studies demonstrated that tirzepatide 40mg markedly enhanced glycemic management and lowered insulin resistance. Furthe